| |
| |
|
| Insider
Information: |
Higgins John L |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,806,928 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$49,065,023 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,806,928 |
|
|
| Total
Value |
$49,065,023 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
11
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -34.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
|
Techne Corp |
TECH |
Director |
2024-05-14 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
165 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-12-12 |
4 |
D |
$64.80 |
$255,571 |
D/D |
(3,944) |
432,984 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-03-08 |
4 |
S |
$107.06 |
$428,240 |
D/D |
(4,000) |
128,969 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-03-20 |
4 |
AS |
$109.10 |
$436,400 |
D/D |
(4,000) |
139,171 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2024-05-14 |
4 |
OE |
$22.95 |
$91,800 |
D/D |
4,000 |
40,608 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2024-05-14 |
4 |
S |
$83.84 |
$335,377 |
D/D |
(4,000) |
36,608 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-02-15 |
4 |
D |
$104.28 |
$448,821 |
D/D |
(4,304) |
118,360 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-07-07 |
4 |
OE |
$56.26 |
$302,098 |
D/D |
4,315 |
204,571 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2023-04-28 |
4 |
D |
$79.88 |
$349,635 |
D/D |
(4,377) |
34,983 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2015-08-06 |
4 |
S |
$110.79 |
$516,946 |
D/D |
(4,666) |
121,378 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-06-21 |
4 |
AS |
$120.00 |
$559,920 |
D/D |
(4,666) |
139,171 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-06-21 |
4 |
OE |
$21.00 |
$97,986 |
D/D |
4,666 |
143,837 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-02-24 |
4 |
D |
$100.38 |
$480,118 |
D/D |
(4,783) |
122,745 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-02-15 |
4 |
D |
$120.86 |
$594,269 |
D/D |
(4,917) |
133,982 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-09-05 |
4 |
AS |
$130.00 |
$650,000 |
D/D |
(5,000) |
139,171 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-09-05 |
4 |
OE |
$21.00 |
$105,000 |
D/D |
5,000 |
144,171 |
0 |
- |
|
| TECH |
Techne Corp |
|
– • – |
2019-06-04 |
4 |
OE |
$63.03 |
$315,150 |
D/D |
5,000 |
8,526 |
0 |
- |
|
| TECH |
Techne Corp |
|
– • – |
2019-06-04 |
4 |
S |
$203.67 |
$1,018,346 |
D/D |
(5,000) |
3,526 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2020-02-12 |
4 |
OE |
$61.46 |
$307,300 |
D/D |
5,000 |
9,021 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2020-02-12 |
4 |
S |
$205.23 |
$1,026,133 |
D/D |
(5,000) |
4,021 |
0 |
% |
|
| TECH |
Techne Corp |
|
– • – |
2020-11-06 |
4 |
OE |
$70.35 |
$351,750 |
D/D |
5,000 |
9,412 |
0 |
- |
|
| TECH |
Techne Corp |
|
– • – |
2020-11-06 |
4 |
S |
$298.98 |
$1,501,744 |
D/D |
(5,000) |
4,412 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-02-13 |
4 |
D |
$95.68 |
$479,261 |
D/D |
(5,009) |
196,730 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-02-15 |
4 |
D |
$97.23 |
$497,429 |
D/D |
(5,116) |
205,173 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-12-28 |
4 |
D |
$138.66 |
$720,893 |
D/D |
(5,199) |
146,050 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-02-15 |
4 |
D |
$172.46 |
$898,862 |
D/D |
(5,212) |
337,848 |
0 |
- |
|
165 Records found
|
|
Page 3 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
